MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47

PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma

(2019) Feng Jiang et al.   BMC CANCER

Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis

(2019) Hongcheng Yang et al.   Cancer Medicine

The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review

(2018) Stephen J. O'Brien et al.   INTERNATIONAL JOURNAL OF CANCER

MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47

(2018) Wei Huang et al.   Molecular Cancer

SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy

(2018) André Veillette et al.   TRENDS IN IMMUNOLOGY

Cancer immunotherapy targeting the CD47/SIRPα axis

(2017) Kipp Weiskopf   EUROPEAN JOURNAL OF CANCER

Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells

(2017) Feng Li et al.   OncoImmunology

CD47: a potential immunotherapy target for eliminating cancer cells

(2016) F. Kong et al.   Clinical & Translational Oncology

MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10

(2016) Xiao-Fang Liu et al.   CLINICAL IMMUNOLOGY

miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction

(2016) Margherita Gigante et al.   Journal of Translational Medicine

Nasopharyngeal carcinoma

(2016) Melvin L K Chua et al.   LANCET

MiR-155–regulated molecular network orchestrates cell fate in the innate and adaptive immune response toMycobacterium tuberculosis

(2016) Alissa C. Rothchild et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint

(2016) Shaohua Xu et al.   Nature Communications

A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer

(2016) Sukhbir Kaur et al.   Oncotarget

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

(2015) Huimin Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nasopharyngeal carcinoma: A review

(2015) Fredrik Petersson   SEMINARS IN DIAGNOSTIC PATHOLOGY

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer

(2015) Kazumichi Yoshida et al.   Cancer Medicine

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential

(2015) Jie Liu et al.   PLoS One

Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma

(2014) Terence Kin-Wah Lee et al.   HEPATOLOGY

miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo

(2014) O Senol et al.   ONCOGENE

Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy

(2014) Thomas Hofner et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

(2014) Limo Chen et al.   Nature Communications

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

(2012) SHIGEMASA SUZUKI et al.   ONCOLOGY REPORTS

Current understanding and management of nasopharyngeal carcinoma

(2011) Tomokazu Yoshizaki et al.   AURIS NASUS LARYNX

MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F

(2011) S. Jurmeister et al.   MOLECULAR AND CELLULAR BIOLOGY

Macrophages as mediators of tumor immunosurveillance

(2010) Siddhartha Jaiswal et al.   TRENDS IN IMMUNOLOGY

miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion

(2009) Hongping Xia et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

(2009) Ravindra Majeti et al.   CELL